Sunil Badve Selected Research

Keratins (Keratin)

1/2019	Three-dimensional imaging and quantitative analysis in CLARITY processed breast cancer tissues.
7/2010	Genomic and immunohistochemical analysis of adenosquamous carcinoma of the breast.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sunil Badve Research Topics

Disease

88	Neoplasms (Cancer) 04/2024 - 12/2002
85	Breast Neoplasms (Breast Cancer) 01/2024 - 01/2002
21	Neoplasm Metastasis (Metastasis) 04/2022 - 12/2003
8	Noninfiltrating Intraductal Carcinoma (DCIS) 02/2024 - 02/2003
8	Thymoma (Thymic Carcinoma) 01/2022 - 05/2010
8	Triple Negative Breast Neoplasms 01/2022 - 11/2011
7	Carcinoma (Carcinomatosis) 11/2017 - 01/2002
4	Residual Neoplasm 01/2023 - 02/2003
4	Adenocarcinoma 04/2009 - 09/2002
2	Margins of Excision 02/2024 - 07/2019
2	Colonic Neoplasms (Colon Cancer) 01/2023 - 03/2015
2	Pneumonia (Pneumonitis) 01/2022 - 11/2002
2	Disease Progression 10/2021 - 04/2009
2	Obesity 01/2020 - 01/2008
2	Brain Neoplasms (Brain Tumor) 11/2017 - 07/2014
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2017 - 12/2010
2	Lobular Carcinoma 07/2013 - 11/2005
2	Seminoma 10/2010 - 10/2007
2	Ductal Carcinoma 11/2005 - 02/2003
1	Hyperglycemia 01/2022
1	Fatigue 01/2022
1	Exanthema (Rash) 01/2022
1	Dyspnea (Shortness of Breath) 01/2022
1	Cough 01/2022
1	Pathologic Complete Response 10/2021
1	Diabetes Mellitus 01/2020
1	Circulating Neoplastic Cells 01/2020
1	Myasthenia Gravis 12/2018
1	Autoimmune Diseases (Autoimmune Disease) 12/2018

Drug/Important Bio-Agent (IBA)

28	Biomarkers (Surrogate Marker)IBA 01/2024 - 03/2003
28	Estrogen ReceptorsIBA 01/2023 - 12/2002
12	Hormones (Hormone)IBA 10/2021 - 04/2007
11	Progesterone Receptors (Progesterone Receptor)IBA 01/2023 - 12/2002
11	Phenobarbital (Luminal)FDA Link 01/2017 - 04/2007
10	RNA (Ribonucleic Acid)IBA 12/2019 - 05/2005
10	Estrogens (Estrogen)FDA Link 01/2016 - 12/2002
10	Proteins (Proteins, Gene)FDA Link 07/2013 - 01/2002
7	DNA (Deoxyribonucleic Acid)IBA 09/2015 - 04/2006
6	Tamoxifen FDA LinkGeneric 02/2024 - 12/2002
6	human ERBB2 proteinIBA 10/2021 - 12/2009
6	ParaffinIBA 12/2019 - 11/2005
6	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2019 - 01/2005
6	Estrogen Receptor alphaIBA 01/2016 - 04/2007
6	Phosphotransferases (Kinase)IBA 01/2013 - 05/2005
5	Messenger RNA (mRNA)IBA 12/2016 - 11/2002
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014 - 01/2006
5	Transcription Factors (Transcription Factor)IBA 01/2010 - 06/2005
4	Immune Checkpoint InhibitorsIBA 04/2024 - 10/2016
4	AnthracyclinesIBA 09/2023 - 12/2009
4	Trastuzumab (Herceptin)FDA Link 01/2022 - 03/2015
4	Formaldehyde (Formol)FDA Link 12/2019 - 04/2009
3	Eosine Yellowish-(YS) (Eosin)IBA 10/2019 - 06/2014
3	Hematoxylin (Haematoxylon)IBA 10/2019 - 06/2014
3	CytokinesIBA 05/2015 - 12/2003
3	Small Interfering RNA (siRNA)IBA 07/2014 - 03/2006
3	Cadherins (E-Cadherin)IBA 07/2013 - 05/2003
3	Docetaxel (Taxotere)FDA Link 06/2007 - 01/2005
2	B7-H1 AntigenIBA 04/2024 - 12/2021
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 07/2014
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2019 - 08/2017
2	Keratins (Keratin)IBA 01/2019 - 07/2010
2	Epidermal Growth Factor (EGF)IBA 03/2016 - 11/2010
2	Nut ProteinsIBA 12/2014 - 09/2013
2	Bevacizumab (Avastin)FDA Link 01/2014 - 10/2008
2	AntibodiesIBA 07/2013 - 09/2002
2	Estradiol (Delestrogen)FDA LinkGeneric 05/2010 - 06/2008
2	Insulin (Novolin)FDA Link 01/2010 - 01/2008
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2010 - 12/2003
2	CarcinogensIBA 11/2009 - 06/2008
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2007 - 12/2006
2	Protein Isoforms (Isoforms)IBA 01/2007 - 12/2006
1	RS 20IBA 04/2022
1	Transaminases (Aminotransferases)IBA 01/2022
1	Capecitabine (Xeloda)FDA Link 01/2022
1	beta-2 Adrenergic ReceptorsIBA 01/2022
1	NVP-BKM120IBA 01/2022
1	gedatolisibIBA 01/2022
1	cofetuzumab pelidotinIBA 01/2022
1	Immunoconjugates (Immunoconjugate)IBA 01/2020
1	Circulating Tumor DNAIBA 01/2020
1	neratinibIBA 01/2020
1	atezolizumabIBA 01/2020
1	pertuzumabIBA 01/2020
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	Icodextrin (Extraneal)FDA Link 01/2020
1	Lapatinib (GW572016)FDA Link 01/2020
1	130-nm albumin-bound paclitaxelIBA 01/2020
1	B 31IBA 01/2019
1	LipidsIBA 01/2019
1	AutoantigensIBA 12/2018

Therapy/Procedure

34	Therapeutics 04/2024 - 01/2006
16	Drug Therapy (Chemotherapy) 09/2023 - 01/2005
6	Neoadjuvant Therapy 01/2023 - 05/2012
4	Radiotherapy 01/2023 - 07/2012
4	Adjuvant Chemotherapy 04/2022 - 12/2009
3	Mastectomy (Mammectomy) 01/2023 - 03/2003
2	Segmental Mastectomy (Lumpectomy) 02/2024 - 02/2003
2	Aftercare (After-Treatment) 09/2015 - 12/2008
2	Precision Medicine 06/2014 - 03/2011
1	Kidney Transplantation 01/2020